))
Benzodiazepines and treatment with Adam Bakker, Michael Liebrenz and Alexander Smith
Manage episode 414580861 series 3532152
Conteúdo fornecido por Rob Calder and Addiction journal. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Rob Calder and Addiction journal ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
In this episode Ben Scher talks to Dr Adam Bakker, Professor Michael Liebrenz and Dr Alexander Smith about their commentary in response to a previous paper by Domzaridou and colleages (2023). They discuss the complexities of providing treatment for people who use, and are prescribed, opiates, opiate agonist medications and benzodiazepines. They talk about using a combination of medical and non-medical treatments when working with people who use benzodiazepines as well as the research needed to bring clarity to this pressing clinical issue.
"This population is notoriously difficult to engage, but we should go the extra mile to retain them in treatment because of this high mortality."
Original Article: Comment on Domzaridou et al.: Recognising the complexities of co-prescriptions and lifestyle factors in opioid agonist treatment by Adam Bakker and colleagues. Published in Addiction (2024).
The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
Hosted on Acast. See acast.com/privacy for more information.
83 episódios
Compartilhar
